Home>Topics>Stocks>Keryx Biopharmaceuticals

Keryx Biopharmaceuticals KERX

  1. All
  2. Commentary
  3. Headlines
    1. 3 Biotech Stocks With Potential

      Headlines

      Tue, 14 May 2013

      that small cap biotech investing can throw at you. The Potential Volatility Of Small Cap Biotech Investing Keryx Biopharmaceuticals ( KERX ) is an early stage biotech company that had been focusing on developing a treatment for kidney disease

    2. Weekly Stock Watch - Week Of May 13, 2013

      Headlines

      Sat, 11 May 2013

      By VFC : Many market analysts and economic pundits have predicted over the past few months that the record-setting highs - although nice while they lasted - would only be short-lived and a pullback or outright market correction was in store. Stocks proved overly resilient, though, and despite some

    3. Keryx Biopharmaceutical's CEO Discusses Q1 2013 Results - Earnings Call Transcript

      Headlines

      Wed, 8 May 2013

      Biopharmaceutical’s ( KERX ) Q1 2013 Earnings Call May 8, 2013 ..... Greetings and welcome to the Keryx Biopharmaceuticals Investor Conference Call ..... Financial Officer for Keryx Biopharmaceuticals . Thank you. Mr. Oliviero ..... conference call regarding Keryx Biopharmaceuticals ’ First Quarter 2013 Financial

    4. Keryx: A Small Biotech With Many Catalysts

      Headlines

      Wed, 8 May 2013

      By George Rho : The shares of Keryx Pharmaceuticals (NASDAQ: KERX ) almost tripled in price in the final four days of January ..... expensive anemia-treating drugs like Amgen's ( AMGN ) Epogen. KERX shares have retreated considerably from the January 31st highs

    5. Keryx ( KERX ): Q1 EPS of -$0.03 misses by $0.02. Revenue of $7M beats by $1.17M. (PR)

      Headlines

      Tue, 7 May 2013

      Keryx ( KERX ): Q1 EPS of -$0.03 misses by $0.02 . Revenue of $7M beats by $1.17M . ( PR ) Post your comment!

    6. Whisper Number Impact: Earnings Preview For Keryx Biopharmaceuticals

      Headlines

      Tue, 7 May 2013

      By WhisperNumber : Keryx Biopharmaceuticals ( KERX ) is expected to report earnings on Wednesday, May 8th ..... number is -$0.01, in-line with the analysts' estimate. KERX has a 33% positive surprise history (having topped the whisper

    7. NewLink Genetics: Looking To Join The Industry's Largest Movers

      Headlines

      Mon, 29 Apr 2013

      just look at the last year alone, there have been countless valuation-changing moves in biotechnology. Keryx Biopharmaceuticals ( KERX ) saw a two-day period where its stock more than doubled after reporting Phase 3 data. Sarepta Therapeutics

    8. Keryx, Zerenex And IP Protection: A PropThink Conference Call

      Headlines

      Mon, 22 Apr 2013

      USPTO. The conference call centered around Keryx Biopharmaceuticals ( KERX ) and its lead drug candidate, Zerenex ..... To read PropThink's previous coverage of Keryx Biopharmaceuticals , click here . David : Welcome to PropThink

    9. Keryx BioPharmaceuticals : A Favorite Of Mine In The Pharmacology World

      Headlines

      Mon, 22 Apr 2013

      article was published here . The story with Keryx BioPharmaceuticals ( KERX ) continues to evolve. I like the potential ..... Biogen Idec Inc. ( BIIB ). The story behind KERX In January, KERX released top-line Phase III about its drug

    10. Here Are The Reasons To Own Keryx And Why Catalysts Are De-Risked

      Headlines

      Fri, 12 Apr 2013

      and long-term patent protection on Zerenex, Keryx's ( KERX ) novel phosphate binder. And with the market still factoring ..... gaining confidence in the IP package could send shares of Keryx Biopharmaceuticals back to their late-January highs. The story, then

    « Prev12345Next »
    Content Partners